戻る Agenda
Session 6: The IND in Detail - Items 8-10
Session Chair(s)
Drusilla Scott, PHD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
- IND Item 8: Nonclinical Pharmacology and Toxicology
- IND Item 9: Previous Human Experience
- IND Item 10: Additional Information